KENNEDY CAPITAL MANAGEMENT LLC
Position in CGEM — Cullinan Therapeutics, Inc.
CIK 884589
ST LOUIS, MO
Position in CGEM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$965,312
+$233,625 QoQ
Shares Held
53,010
+3.0% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#79
of 183 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $451,584,893 across 62 Biotechnology names. CGEM ranks #55 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
544,994 | $42,656,680 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
193,215 | $21,452,661 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
724,508 | $17,576,564 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
201,979 | $17,562,074 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
134,019 | $16,428,049 | |
| 6 | MGTX |
MeiraGTx Holdings plc
|
1,105,421 | $14,934,237 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,755,152 | $14,690,622 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
421,374 | $14,280,364 |
All Filings in CGEM
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $965,312 | 53,010 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $731,687 | 51,491 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $489,203 | 47,266 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $272,845 | 46,011 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $91,670 | 12,174 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $88,137 | 11,643 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,352,576 | 111,049 | Shares | Sole | 2025-02-13 | |
| 2024-03-31 | $1,435,347 | 84,234 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,630,522 | 160,012 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,429,486 | 489,446 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,831,080 | 541,922 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,983,956 | 584,942 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,473,363 | 613,589 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,190,826 | 638,910 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $440,328 | 34,347 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||